Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amn Healthcare Services (AMN) EBITDA (2016 - 2025)

Amn Healthcare Services' EBITDA history spans 16 years, with the latest figure at -$7.7 million for Q4 2025.

  • For Q4 2025, EBITDA rose 95.91% year-over-year to -$7.7 million; the TTM value through Dec 2025 reached -$95.4 million, up 34.92%, while the annual FY2025 figure was -$95.4 million, 34.92% up from the prior year.
  • EBITDA reached -$7.7 million in Q4 2025 per AMN's latest filing, down from $29.4 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $145.1 million in Q1 2022 to a low of -$187.5 million in Q4 2024.
  • Average EBITDA over 5 years is $37.0 million, with a median of $57.1 million recorded in 2023.
  • Peak YoY movement for EBITDA: skyrocketed 1144.14% in 2021, then crashed 1579.08% in 2024.
  • A 5-year view of EBITDA shows it stood at $115.9 million in 2021, then decreased by 29.29% to $81.9 million in 2022, then plummeted by 84.53% to $12.7 million in 2023, then plummeted by 1579.08% to -$187.5 million in 2024, then skyrocketed by 95.91% to -$7.7 million in 2025.
  • Per Business Quant, the three most recent readings for AMN's EBITDA are -$7.7 million (Q4 2025), $29.4 million (Q3 2025), and -$116.1 million (Q2 2025).